Tratamiento con vincristina de tres tumores vasculares con fenómeno de Kasabach-Merritt

Cordisco, María Rosa; Olivera, Alejandro; Lanoël, Agustina; Stefano, Paola; Feliu Torres, Aurora; Sciuccati, Gabriela; Bellani, Patricia; Wright, Daniel; Goldberg, Julio; Pierini, Adrián Martín.
Dermatol. pediátr. latinoam. (Impr.) ; 5(2): 139-146, mayo.-ago. 2007. ilus
Artigo em Espanhol | LILACS, InstitutionalDB, BINACIS, UNISALUD | ID: biblio-1362198

Documentos relacionados

  1. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
  2. Long-term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges.
  3. Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma.
  4. Kasabach-Merritt Syndrome: a case study of successful treatment with vincristine and propranolol.
  5. Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
  6. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
  7. A kaposiform haemangioendothelioma successfully treated with topical tacrolimus and compression bandaging.
  8. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
  9. Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial.
  10. Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.